MEDISCOPE | ISSUE 2 | 02 DECEMBER 2020
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
to survive exposure to the antibiotics that kill
them. Mutations in the genome of bacteria may
cause resistance and are passed on to offspring.
Resistant genes may be in plasmids which can be
transferred to offspring, or they may be directly
inserted into the circular DNA as pathogenicity
islands.
What does antibiotic resistance mean for public
health services?
Antibiotic resistance has become an increasingly
prevalent problem, and by 2050 superbugs could
kill more people than cancer. In the United States
more than 23 000 people die from resistant
bacteria each year.
MRSA is now commonly associated with hospitals.
The over sterile conditions provide the perfect
place for staphylococcus aureus to be exposed to
antibiotics and become resistant to them.
According to the annual epidemiological report by
Public Health England, the all-case rate of MRSA
dropped from 2007/08 to 2018/19 by 7.2 per
100,000 however recently this decline has
stopped: the average rate of MRSA cases has
6
remained stable from 2015 to 2019. The same
observation can be made in the United States. The
CDC saw the rate of MRSA cases decrease by 17.1%
each year from 2005 to 2012. However from 2013
7
to 2016 no significant change was detected.
For public health services antibiotic resistance is a
very significant threat. Many treatments require
the use of antibiotics so that the patient does not
suffer from bacterial infections that could worsen
their condition. For example, those undergoing
chemotherapy are more vulnerable to infection
and require antibiotics. Additionally, the second
major cause of death of those on dialysis
treatment is infection, which makes antibiotics
vital for the patient’s survival. Furthermore those
receiving organ transplants have to take immunosuppressant
drugs which also increase the risk of
infection.
How do we tackle resistant bacteria?
Microbiologists have been using genome
sequencing technology to map the genome of
species of bacteria. This means a mutant resistant
strain can be compared with the existing sequence
of the normal bacteria genome to see exactly
which genes are causing the resistance.
There are also ways of slowing the spread of
antibiotic resistance. The overuse of antibiotics is
one of the major causes of antibiotic resistance.
Therefore healthcare professionals should only
prescribe antibiotics in cases of severe bacterial
infection. Patients should be cautious and finish
the antibiotic course exactly as specified so that
the stronger bacteria do not remain and duplicate.
Viral infections such as influenza do not require
antibiotics.
However there are some causes of antibiotic
resistance that individuals cannot directly control.
For example, in some countries, antibiotics used in
livestock are not regulated and many animals
involved in meat production are overfed
antibiotics. This overuse provides the opportunity
for bacteria to become resistant. However the EU
did introduce regulations in 2006 to stop this
misuse in Europe but there are still many countries
that do not impose laws on this issue.
Bacteriophages
There are one group of non-living organisms that
can destroy bacteria: bacteriophages. They are
viruses that specialise to kill specific types of
bacteria. Up to 40% of bacteria in the ocean are
killed by bacteriophages. They work by inserting
their genetic material into them and releasing an
enzyme called endolysin that punctures a hole in
the bacterium. The pressure builds and the
bacterium bursts releasing many more
bacteriophages.
Bacteriophages are not harmful to humans and as
bacteria evolve, bacteriophages do also. The good
news for humanity is that in order for bacteria to
become resistant to bacteriophages they would
have to give up their resistance to antibiotics.
The Future
Unfortunately, bacteriophage treatment is still
experimental and pharmaceutical companies are
reluctant to invest in a treatment without
approval. A worldwide pioneer clinical trial of
phage therapy was conducted between 2013 and
8
2017 and produced informative results. Hopefully
more research will be conducted into
bacteriophages because we do need a solution to
antibiotic resistance. We need one quickly.
A Bacterium
8
ANTIBIOTIC RESISTANCE